Rising geriatric population and increasing pollution levels are expected to drive the demand for India respiratory inhalers market for the forecast period.
According to TechSci Research report, “India Respiratory Inhalers Market By Product Type (Dry Powder Inhaler, Metered Dose Inhaler, Others), By Technology (Manually Operated Inhalers v/s Digitally Operated Inhalers), By Disease Indication (COPD, Asthma, Pulmonary Atrial Hypertension, Others), By Distribution Channel (Online v/s Offline), By End User (Hospitals & Clinics, Homecare, Others), By Company, By Region, Forecast & Opportunities, FY2027”, India Respiratory Inhalers market is expected to witness steady growth for the next five years. Increasing incidences of respiratory diseases is a major disorder and need effective treatment. Asthma, COPD, and pulmonary diseases are the most common respiratory related diseases. To cure the prevailing respiratory diseases, the need for respiratory inhalers is on rise. Inhalers’ major advantage is that the drug directly travels into the respiratory system thereby is very effective in nature. They are majorly available as soft mist inhalers and breathing actuated inhalers. Each inhaler consists of metered dosage. Due to benefits and rising demand for inhalers, government is supporting the production of respiratory inhalers. Rise in initiatives by government authorities to provide affordable and accessible medication is driving the marker demand. Respiratory inhalers are provided at reasonable rates to patients. High-end investments by manufacturers to increase the product efficiency and increase the product awareness is increasing the product demand in the region. Increasing preference towards adoption of smoking and drinking habits due to increased expenditure capacity and to cope up with high-level of stress affects the respiratory system adversely and gives rise to a number of pulmonary diseases.
Due to the ongoing pandemic COVID-19, lockdown was imposed all over the country. Complete shutdown was observed, and people started practicing social distancing and avoided going out to avail healthcare facilities. Demand for respiratory inhalers, especially allergy and asthma curing respiratory inhalers is increasing at a rapid pace. Health professionals are advising patients to stay indoors as a precautionary measure. Consumers are preferring home medications which is accelerating the demand for respiratory inhalers. Rising awareness regarding respiratory diseases and increasing production of respiratory inhalers is expected to fuel the growth of the market till the forecast period. However, lack of knowledge about the usage of respiratory inhalers may hamper the market growth during the forecast period.
Browse XX Figures spread through XX Pages and an in-depth TOC on “India Respiratory Inhalers Market”.
https://www.techsciresearch.com/report/india-respiratory-inhalers-market/7468.html
Based on technology, market is further bifurcated into manually operated inhalers and digitally operated inhalers. Manually operated inhalers are dominating the respiratory inhalers market for the forecast period as digital technology is still at developing stage. Primary aim for respiratory inhalers is to effectively deliver the drug for effective treatment of respiratory related illnesses. Advancements in technology to optimize the performance of respiratory illness such as increasing the precision of drug dosage, quick action of inhalers and systematic absorption inside the body is expected to boost the demand for respiratory inhalers. Based on disease indication, market is majorly divided into COPD, asthma, pulmonary atrial hypertension, and others. COPD segment is accounted to major market share in the predicted period due to high prevalence of disease in the region and the increasing deaths occurred due to people suffering from COPD. Increasing demand for effective treatment is aiding to high market growth. Government initiatives to promote quality healthcare services to patients and reimbursement plans is contributing to increasing demand for respiratory inhalers in the region.
Philips India Limited, Cipla Limited, Teva API India Limited, Astra Zeneca Pharma India Limited, GlaxoSmithKline Pharmaceuticals Ltd, Omron Healthcare India Pvt. Ltd., Novartis India Ltd., 3M India ltd, Glenmark Pharmaceuticals Limited, Merck India are the leading players operating in the India respiratory inhalers market. Manufacturers are increasingly focusing on research and development process to fuel higher growth in the market. To meet evolving customer demand with respect to better efficiency and durability, several respiratory inhalers manufacturers are coming up with their technologically advanced offerings.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7468
Customers can also request for 10% free customization on this report.
“Adoption of latest technologies by inhalers manufacturing companies in form of smart inhalers which uses Bluetooth technology to gather the required information and remind patients to take medication at proper time. Smart inhalers are integrated with sensors and alerts when a patient enters a highly polluted or high pollen area. Smart inhalers can be digitally connected to laptops or smart devices and other benefits is expected to propel the demand for respiratory inhalers throughout the forecast period” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based global management consulting firm.
“India Respiratory Inhalers Market By Product Type (Dry Powder Inhaler, Metered Dose Inhaler, Others), By Technology (Manually Operated Inhalers v/s Digitally Operated Inhalers), By Disease Indication (COPD, Asthma, Pulmonary Atrial Hypertension, Others), By Distribution Channel (Online v/s Offline), By End User (Hospitals & Clinics, Homecare, Others), By Company, By Region, Forecast & Opportunities, FY2027” has evaluated the future growth potential of India respiratory inhalers market and provided statistics & information on market size, shares, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in the India respiratory inhalers market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]